Tenon Medical is trading at $3.84, down 6.11%, with no company-specific news found to explain the decline.
- The September 30 full commercial launch of SImmetry+ followed an alpha launch that generated approximately $1.2 million in incremental revenue; this prior-session catalyst is not a confirmed explanation for the October 1 decline.
- Healthcare is down 1.33% in the regular session, while broader indices are higher, so the decline does not appear to track the overall market.